Invozenrix Pharma Private Limited
About Invozenrix Pharma Private Limited
Data last updated:
Invozenrix Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 May 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2013PTC088054. Its GSTIN is 36AADCI2762B2ZW (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramalakshmi Bulusu and Bhanu Teja Bulusu.
Its last annual general meeting (AGM) was held on 30 June 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office is at Plot No. 1280 Flat No. 302 Lotus Akhila Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090.
As per the financials filed for FY 2017, the company reported a revenue of ₹36.32 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net loss of ₹54.03 Lakh (net margin -1.5%) and EBITDA of -₹53.91 Lakh (EBITDA margin -1.5%).
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Invozenrix Pharma has one previous CIN (Corporate Identification Number): U24232AP2013PTC088054. The current CIN is U24232TG2013PTC088054, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2013PTC088054 | Current |
| U24232AP2013PTC088054 | Previous |
Contact details
Invozenrix Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 1280 Flat No. 302 Lotus Akhila Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Invozenrix Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Invozenrix Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Invozenrix Pharma Private Limited, buy the company report.
Financials of Invozenrix Pharma Private Limited
FY 2017 filings availableInvozenrix Pharma Private Limited reported revenue of ₹36.32 Cr (up 17% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 17% in the latest year. EBITDA fell 231% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹36.32 Cr | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹53.91 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹54.03 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -1.5% | ||
| Net Profit Margin | -1.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Invozenrix Pharma Private Limited, buy the company report.
Board of directors of Invozenrix Pharma Private Limited
Invozenrix Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramalakshmi Bulusu Also directs: RNT Pharma Private Limited, Digital Taas India Private Limited | Director | 30 May 2013 | 13 Years 4 Months | Current |
| Bhanu Teja Bulusu | Director | 30 May 2013 | 13 Years 4 Months | Current |
Peer comparison
Invozenrix Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abhinav Biotech Private Limited | ₹36.48 Cr (FY 2024) | 39.0% | Delhi, India | |||
| Rockmed Pharma Private Limited | ₹36.45 Cr (FY 2024) | -28.0% | New Delhi, Delhi, India | |||
| Invozenrix Pharma Private Limitedthis company | ₹36.32 Cr (FY 2017) | -₹54.03 Lakh | -1.5% | 17.0% | Hyderabad, Telangana, India | |
| World of Organics Global Private Limited | ₹36.26 Cr (FY 2025) | 20.0% | Delhi, India | |||
| Jayhida Medicare Private Limited | ₹35.94 Cr (FY 2025) | 13.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Invozenrix Pharma Private Limited, buy the company report.
Auditor
Invozenrix Pharma Private Limited is audited by SIVA KRISHNA & NARAYAN for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SIVA KRISHNA & NARAYAN | FY 2017 | 003883S |
Shareholding
The shareholding of Invozenrix Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Invozenrix Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Invozenrix Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Invozenrix Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Invozenrix Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCI2762B2ZW | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Invozenrix Pharma Private Limited, buy the company report.
Recent activity
Invozenrix Pharma Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Uma Shankar Korella ceased to be Additional Director on 29 Sep 2014.
Frequently asked questions
Invozenrix Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 May 2013 (13+ years old) and is registered under CIN U24232TG2013PTC088054.
Invozenrix Pharma has 2 current directors:
- Ramalakshmi Bulusu - Director
- Bhanu Teja Bulusu - Director
The latest financial statements of Invozenrix Pharma on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 June 2017. Year-wise statements from 2015 are in the company report.
The GSTIN of Invozenrix Pharma is 36AADCI2762B2ZW, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Invozenrix Pharma is U24232TG2013PTC088054. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Invozenrix Pharma was incorporated on 30 May 2013, making it 13+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Invozenrix Pharma by revenue are Abhinav Biotech Private Limited, Rockmed Pharma Private Limited, World of Organics Global Private Limited, Jayhida Medicare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Uma Shankar Korella ceased to be Additional Director on 29 Sep 2014. Bhanu Teja Bulusu was appointed as Director on 30 May 2013. Ramalakshmi Bulusu was appointed as Director on 30 May 2013.
The registered office of Invozenrix Pharma is at Plot No. 1280 Flat No. 302 Lotus Akhila Pragathi Nagar Kukatpally, Hyderabad, Telangana, India – 500090.
Invozenrix Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Invozenrix Pharma is active non-compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.